essential hypertension
Conditions
Interventions
control group:Oral administration of dipine antihypertensive drugs and Mongolian Mind–Body Interactive therapy
experimental group:Mongolian Mind–Body Interactive therapy
Sponsors
Inner Mongolia Traditional Chinese& Mongolian Medical Research Institute
Eligibility
Sex/Gender
All
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: ? Age range from 45 to 60 years old, regardless of gender; ? Primary hypertension (diagnosed based on the revised 2018 edition of the Chinese Guidelines for the Prevention and Treatment of Hypertension) is a mild to moderate condition that meets the diagnostic criteria for primary hypertension and meets the risk classification for hypertension: low or medium risk. Patients who have not taken antihypertensive drugs since diagnosis or have only taken dipine antihypertensive drugs; ? Be able to maintain contact and cooperate with the requirements of this study during the treatment period; ? If the four tests for infection are negative, an electrocardiogram and liver, gallbladder, pancreas, spleen, kidney, and portal vein system examination in the past week can be provided; ? Can provide clinical examination project reports for the past half month: EEG, 24-hour dynamic electrocardiogram, chest CT, abdominal ultrasound (liver, gallbladder, pancreas, spleen, kidney, and portal vein system examination), cardiac color Doppler ultrasound examination, blood routine, major biochemistry (liver function, kidney function, ions, blood glucose, blood lipids, myocardial enzyme spectrum, etc.), inflammatory factors (C-reactive protein (CPR) measurement, erythrocyte sedimentation rate (ESR) measurement); ? Collaborate with collecting peripheral blood four times (before treatment and after 1, 4, and 8 weeks of treatment), as well as morning urine and saliva. ? Those who voluntarily participate in this clinical study and sign informed consent.
Exclusion criteria
Exclusion criteria: ? Pregnant, breastfeeding, or taking birth control pills. ? Patients who are currently participating in other clinical trials or have participated in other clinical trials within the past month. ? Patients who have consumed Western medicine, Mongolian medicine, traditional Chinese medicine, or other traditional medicine treatments other than antihypertensive drugs within 2 weeks, as well as those who have participated in Mongolian medicine psychosomatic interaction therapy, need to stop for more than 2 weeks before they can participate in this study. ? Having a current state or medical history of mental illness, or a history of alcohol or drug abuse, which affects compliance with the research protocol. ? And any other circumstances that may affect the research results, as determined by the doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood pressure;SF36; | — |
Secondary
| Measure | Time frame |
|---|---|
| electroencephalogram;C-reactive protein;Self Rating Depression Scale;Anxiety Self Rating Scale; | — |
Countries
China
Contacts
Public ContactNAGONGBILIGE
Inner Mongolia Traditional Chinese& Mongolian Medical Research Institute
Outcome results
None listed